Invention Grant
- Patent Title: Tryptamine prodrugs
-
Application No.: US17364047Application Date: 2021-06-30
-
Publication No.: US11292765B2Publication Date: 2022-04-05
- Inventor: Nathan Bryson
- Applicant: Field Trip Psychedelics Inc.
- Applicant Address: CA Toronto
- Assignee: Field Trip Psychedelics Inc.
- Current Assignee: Field Trip Psychedelics Inc.
- Current Assignee Address: CA Toronto
- Agency: McAndrews, Held & Malloy, Ltd.
- Agent Michael Stanley Tomsa
- Main IPC: C07D209/16
- IPC: C07D209/16 ; C07D209/08 ; A61K9/08 ; A61K9/00 ; A61K9/20
Abstract:
The present invention provides a tryptamine prodrug compound. A compound represented by the formula (I) where each symbol is as described in the specification, or a salt or zwitterion thereof, is converted to an active which has 5HT2A receptor agonist activity, and is useful as an agent for the treatment of depression.
Public/Granted literature
- US20210403425A1 TRYPTAMINE PRODRUGS Public/Granted day:2021-12-30
Information query
